title: Are we nearsighted when it comes to myopia treatment?
abstract: OBJECTIVE
  The purpose of this article is to highlight the current research on myopia treatment and to speculate about the future of myopia treatment.
  
  
  METHODS
  A review of the literature on myopia treatment in humans was performed using Medline, CRISP, and a variety of web pages. A summary of the research is presented in the article.
  
  
  RESULTS
  Most of myopia research can be categorized into three areas: control, treatment, and prevention. Most of independent myopia research currently conducted is in the area of control. Great advances in the myopia treatment are constantly being practiced, but few independent investigations are conducted. Methods of predicting the future onset of myopia are being investigated to some day allow us to apply preventive agents before myopia occurs.
  
  
  CONCLUSIONS
  Two randomized clinical trials are scheduled for completion within the next year, and they should offer answers about mechanisms of myopia control. Treatments for myopia are moving beyond questions of safety and efficacy and on to reductions of complications and refinement of vision to produce super vision. At least one eye drop, pirenzepine, is being investigated for myopia control and may show promise for prevention of myopia in the future.
authors.affiliation: The Ohio State University College of Optometry, 338 West Tenth Avenue, Columbus, OH 43210-1240, USA. walline.1@osu.edu
authors.forename: Jeffrey J
authors.initials: JJ
authors.lastname: Walline
mesh_terms: D035843:Biomedical Research; D003261:Contact Lenses; D004358:Drug Therapy; D005139:Eyeglasses; D006801:Humans; D009216:Myopia / Q000517:prevention & control / Q000628:therapy*; D013508:Ophthalmologic Surgical Procedures; D016032:Randomized Controlled Trials as Topic